Wijesinghe P - Search Results

1

Efficient deamination of 5-methylcytosines in DNA by human APOBEC3A, but not by AID or APOBEC3G.

Wijesinghe P, Bhagwat AS. Wijesinghe P, et al. Nucleic Acids Res. 2012 Oct;40(18):9206-17. doi: 10.1093/nar/gks685. Epub 2012 Jul 13. Nucleic Acids Res. 2012. PMID: 22798497 Free PMC article.

2

Determinants of sequence-specificity within human AID and APOBEC3G.

Carpenter MA, Rajagurubandara E, Wijesinghe P, Bhagwat AS. Carpenter MA, et al. Among authors: wijesinghe p. DNA Repair (Amst). 2010 May 4;9(5):579-87. doi: 10.1016/j.dnarep.2010.02.010. Epub 2010 Mar 24. DNA Repair (Amst). 2010. PMID: 20338830 Free PMC article.

3

Integrating 5hmC and gene expression data to infer regulatory mechanisms.

Mitrea C, Wijesinghe P, Dyson G, Kruger A, Ruden DM, Draghici S, Bollig-Fischer A. Mitrea C, et al. Among authors: wijesinghe p. Bioinformatics. 2018 May 1;34(9):1441-1447. doi: 10.1093/bioinformatics/btx777. Bioinformatics. 2018. PMID: 29220513 Free PMC article.

4

A mass spectrometry assay to simultaneously analyze ROS1 and RET fusion gene expression in non-small-cell lung cancer.

Wijesinghe P, Bepler G, Bollig-Fischer A. Wijesinghe P, et al. J Thorac Oncol. 2015 Feb;10(2):381-6. doi: 10.1097/JTO.0000000000000337. J Thorac Oncol. 2015. PMID: 25384172 Free PMC article.

5

Lung Cancer Genomics in the Era of Accelerated Targeted Drug Development.

Wijesinghe P, Bollig-Fischer A. Wijesinghe P, et al. Adv Exp Med Biol. 2016;890:1-23. doi: 10.1007/978-3-319-24932-2_1. Adv Exp Med Biol. 2016. PMID: 26703796 Review.

6

Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity.

Bao B, Mitrea C, Wijesinghe P, Marchetti L, Girsch E, Farr RL, Boerner JL, Mohammad R, Dyson G, Terlecky SR, Bollig-Fischer A. Bao B, et al. Among authors: wijesinghe p. Sci Rep. 2017 Mar 10;7:44125. doi: 10.1038/srep44125. Sci Rep. 2017. PMID: 28281569 Free PMC article.

7

Cytogenomic profiling of breast cancer brain metastases reveals potential for repurposing targeted therapeutics.

Bollig-Fischer A, Michelhaugh SK, Wijesinghe P, Dyson G, Kruger A, Palanisamy N, Choi L, Alosh B, Ali-Fehmi R, Mittal S. Bollig-Fischer A, et al. Among authors: wijesinghe p. Oncotarget. 2015 Jun 10;6(16):14614-24. doi: 10.18632/oncotarget.3786. Oncotarget. 2015. PMID: 25970776 Free PMC article.

8

A Retrospective Comparative Chart Review of Hearing Recovery in Neural and Sensory Type Sudden Sensorineural Hearing Loss Patients.

Xu RZ, Guo RC, Wijesinghe P, Joshua TG, Ayub A, Lee M, Nunez DA. Xu RZ, et al. Among authors: wijesinghe p. J Laryngol Otol. 2024 May 20:1-19. doi: 10.1017/S0022215124000781. Online ahead of print. J Laryngol Otol. 2024. PMID: 38763907 No abstract available.

9

Synthesis and Evaluation of a Novel PET Radioligand for Imaging Glutaminyl Cyclase Activity as a Biomarker for Detecting Alzheimer's Disease.

Behof WJ, Haynes JR, Whitmore CA, Cheung YY, Tantawy MN, Peterson TE, Wijesinghe P, Matsubara JA, Pham W. Behof WJ, et al. Among authors: wijesinghe p. ACS Sens. 2024 May 24;9(5):2605-2613. doi: 10.1021/acssensors.4c00313. Epub 2024 May 8. ACS Sens. 2024. PMID: 38718161 Free PMC article.

10

Light-deformable microrobots shape up for the biological obstacle course.

Wijesinghe P. Wijesinghe P. Light Sci Appl. 2024 May 6;13(1):103. doi: 10.1038/s41377-024-01448-8. Light Sci Appl. 2024. PMID: 38710694 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

152 results

Search Page